Hackensack Meridian Health John Theurer Cancer Center (JTCC), part of the NCI-designated Georgetown Lombardi Comprehensive Cancer Center announced today an affiliation with Regional Cancer Care Associates (RCCA), a medical oncology/hematology practice in Toms River, NJ.
The practice, called Toms River Regional Cancer Center, will offer comprehensive medical and surgical oncology/hematology consultative services by community-based, regional, and national experts for all types and stages of cancer and serious blood disorders. The facility will also provide full infusion services, genomics analysis, and access to cutting-edge clinical trials. All care will be provided in accordance with JTCC quality standards and protocols. Internationally renowned researchers from JTCC will conduct specialty clinics at the location in addition to full-time RCCA oncology clinicians.
“The affiliation with Regional Cancer Care Associates is a key component of our efforts to bring together private oncology practices throughout the state of New Jersey with the aim of providing state-of-the-art cancer care and research to local communities,” said Andre Goy, M.D., MS, Chairman and Director of John Theurer Cancer Center (JTCC) at Hackensack University Medical Center. “The medical oncologists at RCCA have been delivering quality care to patients in the Toms River area for decades, and we are pleased to formalize our collaborative relationship with them under the umbrella of our new affiliation.”
The medical and surgical oncologists at RCCA will continue to provide patient care to the local community as part of the JTCC network. Patients who are eligible to participate in JTCC clinical trials will be able to visit the RCCA satellite facility to consult with study staff and receive treatment as part of a study protocol.
“Affiliation with the John Theurer Cancer Center will help make Regional Cancer Care Associates a full-fledged cancer center that provides compassionate, multi-disciplinary care from medical oncologists and hematologists, facilitates access to cutting-edge clinical trials, and offers surgical, radiation oncology, genetic testing, and nursing services to the Toms River area,” stated Gurpreet S. Lamba, MD, a board-certified specialist in hematology/oncology, and a partner in RCCA. “Rather than having to travel long distances, patients in Monmouth and Ocean Counties can now get the complete package of care they richly deserve, right here in their backyard.”
In 2019, JTCC became part of the National Cancer Institute (NCI)-designated Georgetown Lombardi Comprehensive Cancer Center. More recently, in August 2020 U.S. News & World Report recognized JTCC as the best cancer center in New Jersey.
“We are thrilled to be formally affiliated with John Theurer Cancer Center, a world-renowned teaching facility that is widely recognized for its comprehensive patient care, research, and education programs,” commented Kenneth D. Nahum, DO, a board-certified specialist in hematology/oncology and internal medicine, and a partner in RCCA. “Whether a patient needs a second opinion consultation, or is a candidate for immunotherapy or targeted therapy, that patient can directly benefit from the expertise of some of the world’s leading experts in cancer care and research, expertise that is now available locally as well as statewide,” added Dr. Nahum, who is also a clinical associate professor at Robert Wood Johnson Medical School and the Cancer Institute of New Jersey.
“Affiliation with John Theurer Cancer Center will enable provision of world-class care to the local community while connecting patients to Centers of Excellence for multiple tumor types,” commented Thomas L. Bauer II, M.D., chair of Surgery and chief of Thoracic Surgery at Jersey Shore University Medical Center. “When patients need surgery, access to those Centers of Excellence will make them more likely to undergo minimally invasive procedures, get out of the hospital faster, experience less pain and fewer complications, and return to work sooner.”
For more information about the Toms River Regional Cancer Center, visit https://www.hackensackmeridianhealth.org/services/cancer-care/toms-river-regional-cancer-center/.
About John Theurer Cancer Center at Hackensack University Medical Center
John Theurer Cancer Center at Hackensack University Medical Center is New Jersey’s best cancer center, as recognized by U.S. News & World Report. This premier cancer center is also the largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancers. The 16 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. Each year, more people in the New Jersey/New York metropolitan area turn to John Theurer Cancer Center for cancer care than to any other facility in New Jersey. John Theurer Cancer Center, part of Georgetown Lombardi Comprehensive Cancer Center, an NCI designated comprehensive cancer center. Housed within a 775-bed not-for-profit teaching, tertiary care, and research hospital, John Theurer Cancer Center provides
state-of-the-art technological advances, compassionate care, research innovations, medical expertise, and a full range of aftercare services that distinguish John Theurer Cancer Center from other facilities. For additional information, please visit www.jtcancercenter.org.
About Regional Cancer Care Associates
With more than 100 cancer specialists practicing at 20+ care centers located throughout New Jersey, Connecticut, Maryland, Pennsylvania, and the Washington, DC area, RCCA provides care to roughly 24,500 new cancer patients and 245,000 established patients each year. RCCA offers those patients immunotherapy, targeted treatment, cell-based therapy and other cutting-edge treatments and diagnostic modalities, as well as access to clinical trials. RCCA is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM), a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment. To learn more about RCCA or to schedule an appointment, call (844) 474-6866 or visit www.RCCA.com.